Evidence map›Paper›PMID 31188885›Full record

ArticlePloS one2019

A design of experiments approach for the rapid formulation of a chemically defined medium for metabolic profiling of industrially important microbes.

Chloe Singleton, James Gilman, Jessica Rollit, Kun Zhang, David A Parker, John Love

Abstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Microbial pathways for advanced biofuel production.Biochemical Society transactions · 2022
    Review
  6. Article
  7. Article
  8. Article
  9. Time-Course Transcriptome ofInternational journal of molecular sciences · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chloe SingletonThe Exeter Microbial Biofuels Group, College of Life and Environmental Sciences, The University of Exeter, Exeter, Devon, United Kingdom.ORCID 0000-0001-7862-4321
James GilmanThe Exeter Microbial Biofuels Group, College of Life and Environmental Sciences, The University of Exeter, Exeter, Devon, United Kingdom.
Jessica RollitDepartment of Life Sciences, Imperial College London, London, United Kingdom.
Kun ZhangShell Technology Centre, Houston, Texas, United States of America.
David A ParkerThe Exeter Microbial Biofuels Group, College of Life and Environmental Sciences, The University of Exeter, Exeter, Devon, United Kingdom.
John LoveThe Exeter Microbial Biofuels Group, College of Life and Environmental Sciences, The University of Exeter, Exeter, Devon, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Geobacillus thermoglucosidans DSM2542 is an industrially important microbe, however the complex nutritional requirements of Geobacilli confound metabolic engineering efforts. Previous studies have utilised semi-defined media recipes that contain complex, undefined, biologically derived nutrients which have unknown ingredients that cannot be quantified during metabolic profiling. This study used design of experiments to investigate how individual nutrients and interactions between these nutrients contribute to growth. A mathematically derived defined medium has been formulated that has been shown to robustly support growth of G. thermoglucosidans in two different environmental conditions (96-well plate and shake flask) and with a variety of lignocellulose-based carbohydrates. This enabled the catabolism of industrially relevant carbohydrates to be investigated.

Indexed as

Culture MediaGeobacillusMetabolomeMetabolomicsCulture Media

Identifiers

PMID31188885
PMCPMC6561596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.